Related Experiment Video

Updated: Jul 4, 2025

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves
11:12

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves

Published on: October 17, 2013

13.8K

Anticoagulant Therapy for Mechanical Heart Valves - Unmet Need Persists

Gary E Raskob1

  • 1University of Oklahoma Health Sciences Center, Oklahoma City.

NEJM Evidence
|February 6, 2024
PubMed

Insights

Direct oral anticoagulants (DOACs) offer effective and safer alternatives to warfarin for preventing blood clots in atrial fibrillation and venous thromboembolism. DOACs provide improved safety with reduced bleeding risks and simplified fixed-dose administration without routine monitoring.

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Hematology

Background:

  • Direct oral anticoagulants (DOACs) represent a significant advancement in anticoagulant therapy.
  • These agents selectively target factor Xa (e.g., apixaban) or thrombin (e.g., dabigatran).

Discussion:

  • DOACs demonstrate comparable efficacy to vitamin K antagonists (VKAs) like warfarin in managing atrial fibrillation and venous thromboembolism.
  • Key safety benefits include a reduced risk of intracranial hemorrhage, fatal bleeding, and all-cause mortality compared to VKAs.

Key Insights:

  • DOACs offer a more convenient treatment regimen with fixed dosing and no requirement for routine laboratory monitoring.
  • This simplifies patient management and potentially improves adherence.

Outlook:

  • The enhanced safety profile and ease of use position DOACs as a preferred choice for anticoagulation.
  • Further research may explore expanded indications and long-term outcomes.

More Related Videos

In Vitro Thrombosis Test for Ventricular Assist Devices09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

594
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

83.6K

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
698
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
525
Heart Valves01:16

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
4.6K